# Mesenchymal Stem Cells to Treat Type 2 Diabetes

> **NCT02302599** · PHASE2 · COMPLETED · sponsor: **Chinese PLA General Hospital** · enrollment: 103 (actual)

## Conditions studied

- Type 2 Diabetes
- Mesenchymal Stem Cells

## Interventions

- **BIOLOGICAL:** Umbilical cord mesenchymal stem cells
- **BIOLOGICAL:** Controlled suspension liquid

## Key facts

- **NCT ID:** NCT02302599
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2021-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02302599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02302599, "Mesenchymal Stem Cells to Treat Type 2 Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02302599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*